Therapeutic effect of
Cerebral ischemia
MRI
PET
metalloproteinases
neuroinflammation
Journal
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism
ISSN: 1559-7016
Titre abrégé: J Cereb Blood Flow Metab
Pays: United States
ID NLM: 8112566
Informations de publication
Date de publication:
08 2023
08 2023
Historique:
pmc-release:
13
03
2024
medline:
21
7
2023
pubmed:
15
3
2023
entrez:
14
3
2023
Statut:
ppublish
Résumé
Nicotinic acetylcholine α7 receptors (α7 nAChRs) have a well-known modulator effect in neuroinflammation. Yet, the therapeutical effect of α7 nAChRs activation after stroke has been scarcely evaluated to date. The role of α7 nAChRs activation with PHA 568487 on inflammation after brain ischemia was assessed with positron emission tomography (PET) using [
Identifiants
pubmed: 36916034
doi: 10.1177/0271678X231161207
pmc: PMC10369150
doi:
Substances chimiques
PHA-568487E
0
alpha7 Nicotinic Acetylcholine Receptor
0
Receptors, Nicotinic
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1301-1316Références
Glia. 2002 Sep;39(3):279-91
pubmed: 12203394
Mol Neurobiol. 2016 Jan;53(1):231-239
pubmed: 25421209
Neurobiol Dis. 2005 Mar;18(2):375-84
pubmed: 15686966
Eur Stroke J. 2016 Mar;1(1):20-27
pubmed: 31008264
Sci Rep. 2019 Jan 24;9(1):507
pubmed: 30679481
J Cereb Blood Flow Metab. 2010 Jan;30(1):230-41
pubmed: 19794397
EJNMMI Res. 2017 Nov 25;7(1):93
pubmed: 29177913
J Cereb Blood Flow Metab. 2008 Oct;28(10):1674-85
pubmed: 18560439
Am J Physiol Cell Physiol. 2019 Feb 1;316(2):C135-C153
pubmed: 30379577
Nature. 2003 Jan 23;421(6921):384-8
pubmed: 12508119
J Labelled Comp Radiopharm. 2017 Jan;60(1):69-79
pubmed: 28004430
Glia. 2018 Aug;66(8):1611-1624
pubmed: 29528142
Neurol Sci. 2007 Aug;28(4):165-70
pubmed: 17690845
BMC Bioinformatics. 2013 Nov 04;14:316
pubmed: 24180558
Front Neurol. 2021 Feb 05;12:619721
pubmed: 33633673
PLoS One. 2014 Aug 26;9(8):e105711
pubmed: 25157794
Br J Pharmacol. 2007 Aug;151(7):915-29
pubmed: 17502850
Cell Death Discov. 2022 Feb 8;8(1):54
pubmed: 35136042
Mol Neurobiol. 2017 Dec;54(10):8278-8286
pubmed: 27914011
Neurobiol Dis. 2016 Jul;91:236-46
pubmed: 27001146
J Cereb Blood Flow Metab. 2015 Nov;35(11):1711-21
pubmed: 26126867
Pharmaceuticals (Basel). 2021 Apr 01;14(4):
pubmed: 33916253
Brain Res. 2021 Jan 15;1751:147196
pubmed: 33159972
Appl Radiat Isot. 2009 Apr;67(4):606-10
pubmed: 19167232
J Thromb Haemost. 2021 Jul;19(7):1618-1628
pubmed: 33834615
Stroke. 1998 Oct;29(10):2189-95
pubmed: 9756602
Magn Reson Imaging. 2007 Jun;25(5):733-5
pubmed: 17540286
Lancet Neurol. 2016 Jul;15(8):869-881
pubmed: 27180033
Auton Neurosci. 2014 May;182:65-9
pubmed: 24411268
Nat Med. 2003 Oct;9(10):1313-7
pubmed: 12960961
Stroke. 2006 Jun;37(6):1399-406
pubmed: 16690896
J Cereb Blood Flow Metab. 2003 Dec;23(12):1430-40
pubmed: 14663338
J Neurochem. 2014 Nov;131(4):498-508
pubmed: 25040630
Int J Mol Sci. 2015 Dec 04;16(12):29029-46
pubmed: 26690125
Ther Adv Neurol Disord. 2018 May 04;11:1756286418774267
pubmed: 29774059
Stroke. 2007 Feb;38(2 Suppl):646-51
pubmed: 17261708
Theranostics. 2021 Jan 1;11(1):410-425
pubmed: 33391483
Stroke. 2022 May;53(5):1473-1486
pubmed: 35387495
J Cereb Blood Flow Metab. 1999 Jun;19(6):624-33
pubmed: 10366192
Front Neurol. 2014 Jun 24;5:107
pubmed: 25009531
Neurosci Lett. 2019 Feb 16;694:9-13
pubmed: 30452951
Br J Pharmacol. 2013 Aug;169(8):1862-78
pubmed: 23713819